RecruitingNot ApplicableNCT07222410

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Closed Loop Oxygen Control in COPD Patients Treated With Nasal High Flow in the Hospital


Sponsor

Fisher and Paykel Healthcare

Enrollment

70 participants

Start Date

Jan 7, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain patients' SpO2 levels within the target range better than manual oxygen titration in hospitalized COPD patients with hypoxemia/respiratory distress.


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a system that automatically adjusts oxygen levels delivered through nasal high-flow therapy in hospitalized COPD patients, rather than requiring manual nurse adjustments. The goal is to keep oxygen levels in the ideal range more consistently and reduce complications. **You may be eligible if...** - You are 22 or older - You are hospitalized with low oxygen levels or breathing difficulties - You have a confirmed COPD diagnosis - Your doctor has prescribed nasal high-flow oxygen therapy (at a flow rate of at least 25 L/min) - You are expected to need oxygen therapy for more than 24 hours **You may NOT be eligible if...** - You are receiving or need non-invasive ventilation (like a CPAP or BiPAP mask) - Your blood pressure is dangerously low or you need vasopressors - You are receiving end-of-life care - You have nose or face conditions preventing nasal high-flow use - You are pregnant or breastfeeding - You have significant cognitive impairment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEClosed loop oxygen control

Nasal high flow with closed loop oxygen control

DEVICEManual titration

Nasal high flow with manual titration


Locations(3)

Central Iowa Hospital Corp - UnityPoint Health

Des Moines, Iowa, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Temple University Hospital

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07222410


Related Trials